Verition Fund Management
SRDX

Verition Fund Management’s Surmodics SRDX Stock Holding History

Verition Fund Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,364
Closed -$1.15M – 3919
2025
Q3 		$1.15M Sell
38,364
-11,402
-23% -$381K ﹤0.01% 2424
2025
Q2 		$1.48M Sell
49,766
-40,902
-45% -$1.18M 0.01% 2180
2025
Q1 		$2.77M Sell
90,668
-332
-0.4% -$11.2K 0.01% 1349
2024
Q4 		$3.6M Buy
+91,000
New +$3.54M 0.01% 1132
2023
Q3 		– Sell
-8,100
Closed -$254K – 2664
2023
Q2 		$254K Sell
8,100
-14,002
-63% -$320K ﹤0.01% 1685
2023
Q1 		$503K Buy
+22,102
New +$569K 0.01% 1229

Other funds holding SRDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's SRDX Position: Q4 2025 in Review

Verition Fund Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 38,364 shares — an estimated $1.15M sold.

Verition Fund Management first reported a position in SRDX in Q1 2023 and held it in 6 quarters. The position peaked at $3.6M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Verition Fund Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 38,364 Surmodics shares in Q4 2025, an estimated $1.15M.
  • Verition Fund Management first reported a position in Surmodics in Q1 2023 and held it in 6 quarters.
  • Verition Fund Management's Surmodics position peaked at $3.6M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.